Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alzheimer's Start-Ups Face A Discovery And Clinical Crossroads

Jul 01 2010

• By Alex Lash

Related Content

The Alzheimer's Divide

Sep 01 2008

AlzProtect SAS

Jul 01 2010

Cognition Therapeutics Inc.

Jul 01 2010

Axerion Therapeutics Inc.

Jul 01 2010

Galantos Pharma GMBH

Jul 01 2010

Related Companies

AlzProtect SAS

Pfizer Inc.

Medivation, Inc.

Myriad Genetics, Inc.

BELLUS Health Inc.

Johnson & Johnson

Eli Lilly and Company

Galantos Pharma GmbH

Axerion Therapeutics Inc.

Yale University

Satori Pharmaceuticals, Inc.

Cognition Therapeutics, Inc.

National Institutes of Health

Link Medicine Corporation

Bristol Myers Squibb Company

Additional Topics

BioPharmaceutical

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.